*Data sourced from different clinical trials. In the OASIS 4 clinical trial, Wegovy tablets were associated with 16.6% average weight loss over 64 weeks, when coupled with a balanced diet and physical activity. In the STEP UP trial 3b, Wegovy 7.2mg injections were associated with 20.7% average weight loss over 72 weeks, when coupled with a balanced diet and physical activity. In the SURMOUNT trial, Mounjaro injections were associated with 25.3% average weight loss over 72 weeks, when coupled with a balanced diet and physical activity.
Clinical trial results are provided for context only. They are not from a head-to-head trial and should not be used to directly compare treatments. Trial design, patient groups, doses and durations differed.
Individual results vary, and treatment is not guaranteed. Your clinician will discuss which treatment options may be suitable for you.
Results vary between individuals. Suitability, side effects and risks will be assessed by a clinician. Chart is for illustrative summary only.



